nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2C18—malignant glioma	0.433	0.574	CbGaD
Cyclophosphamide—CYP2B6—malignant glioma	0.322	0.426	CbGaD
Cyclophosphamide—Myeloid leukaemia—Temozolomide—malignant glioma	0.0081	0.0519	CcSEcCtD
Cyclophosphamide—Radiation injury—Temozolomide—malignant glioma	0.0081	0.0519	CcSEcCtD
Cyclophosphamide—Venoocclusive disease—Carmustine—malignant glioma	0.00762	0.0489	CcSEcCtD
Cyclophosphamide—Lung fibrosis interstitial—Carmustine—malignant glioma	0.00762	0.0489	CcSEcCtD
Cyclophosphamide—Wound—Carmustine—malignant glioma	0.00606	0.0388	CcSEcCtD
Cyclophosphamide—Metastatic neoplasm—Temozolomide—malignant glioma	0.00443	0.0284	CcSEcCtD
Cyclophosphamide—Myelodysplastic syndrome—Temozolomide—malignant glioma	0.00423	0.0271	CcSEcCtD
Cyclophosphamide—Pulmonary toxicity—Carmustine—malignant glioma	0.00387	0.0248	CcSEcCtD
Cyclophosphamide—Infertility—Carmustine—malignant glioma	0.00337	0.0216	CcSEcCtD
Cyclophosphamide—Infertility—Temozolomide—malignant glioma	0.00325	0.0209	CcSEcCtD
Cyclophosphamide—Fibrosis—Carmustine—malignant glioma	0.00308	0.0197	CcSEcCtD
Cyclophosphamide—Acute leukaemia—Carmustine—malignant glioma	0.00308	0.0197	CcSEcCtD
Cyclophosphamide—Ifosfamide—CYP2C18—malignant glioma	0.00306	0.448	CrCbGaD
Cyclophosphamide—Acute leukaemia—Temozolomide—malignant glioma	0.00297	0.0191	CcSEcCtD
Cyclophosphamide—Nephrotoxicity—Carmustine—malignant glioma	0.00276	0.0177	CcSEcCtD
Cyclophosphamide—Pigmentation disorder—Temozolomide—malignant glioma	0.00254	0.0163	CcSEcCtD
Cyclophosphamide—Ifosfamide—CYP2B6—malignant glioma	0.00227	0.333	CrCbGaD
Cyclophosphamide—Impaired healing—Carmustine—malignant glioma	0.00203	0.013	CcSEcCtD
Cyclophosphamide—Myelosuppression—Carmustine—malignant glioma	0.00187	0.012	CcSEcCtD
Cyclophosphamide—Myelosuppression—Temozolomide—malignant glioma	0.00181	0.0116	CcSEcCtD
Cyclophosphamide—Interstitial pneumonia—Temozolomide—malignant glioma	0.00176	0.0113	CcSEcCtD
Cyclophosphamide—Nephropathy toxic—Carmustine—malignant glioma	0.00153	0.00981	CcSEcCtD
Cyclophosphamide—Ifosfamide—PTGS1—malignant glioma	0.00149	0.219	CrCbGaD
Cyclophosphamide—Skin hyperpigmentation—Carmustine—malignant glioma	0.00148	0.00948	CcSEcCtD
Cyclophosphamide—Febrile neutropenia—Carmustine—malignant glioma	0.00146	0.00937	CcSEcCtD
Cyclophosphamide—Febrile neutropenia—Temozolomide—malignant glioma	0.00141	0.00905	CcSEcCtD
Cyclophosphamide—Encephalopathy—Carmustine—malignant glioma	0.00137	0.00878	CcSEcCtD
Cyclophosphamide—Embolism—Temozolomide—malignant glioma	0.00132	0.00849	CcSEcCtD
Cyclophosphamide—Parosmia—Temozolomide—malignant glioma	0.00131	0.0084	CcSEcCtD
Cyclophosphamide—Interstitial lung disease—Carmustine—malignant glioma	0.00124	0.00796	CcSEcCtD
Cyclophosphamide—Thrombosis—Carmustine—malignant glioma	0.00124	0.00796	CcSEcCtD
Cyclophosphamide—Interstitial lung disease—Temozolomide—malignant glioma	0.0012	0.0077	CcSEcCtD
Cyclophosphamide—Menorrhagia—Temozolomide—malignant glioma	0.00115	0.00736	CcSEcCtD
Cyclophosphamide—Hepatotoxicity—Carmustine—malignant glioma	0.00114	0.0073	CcSEcCtD
Cyclophosphamide—Herpes zoster—Temozolomide—malignant glioma	0.00113	0.00723	CcSEcCtD
Cyclophosphamide—Necrosis—Carmustine—malignant glioma	0.00112	0.00718	CcSEcCtD
Cyclophosphamide—Cholestasis—Temozolomide—malignant glioma	0.00112	0.00717	CcSEcCtD
Cyclophosphamide—Hepatotoxicity—Temozolomide—malignant glioma	0.0011	0.00705	CcSEcCtD
Cyclophosphamide—Injection site pain—Carmustine—malignant glioma	0.00108	0.0069	CcSEcCtD
Cyclophosphamide—Extravasation—Carmustine—malignant glioma	0.00101	0.00646	CcSEcCtD
Cyclophosphamide—Amenorrhoea—Temozolomide—malignant glioma	0.000967	0.0062	CcSEcCtD
Cyclophosphamide—Drug interaction—Carmustine—malignant glioma	0.000947	0.00608	CcSEcCtD
Cyclophosphamide—Viral infection—Temozolomide—malignant glioma	0.00094	0.00603	CcSEcCtD
Cyclophosphamide—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.000934	0.00599	CcSEcCtD
Cyclophosphamide—Hepatic enzyme increased—Temozolomide—malignant glioma	0.000898	0.00576	CcSEcCtD
Cyclophosphamide—Hearing impaired—Temozolomide—malignant glioma	0.000892	0.00572	CcSEcCtD
Cyclophosphamide—Pulmonary embolism—Carmustine—malignant glioma	0.000879	0.00564	CcSEcCtD
Cyclophosphamide—Respiratory failure—Temozolomide—malignant glioma	0.000865	0.00555	CcSEcCtD
Cyclophosphamide—Pulmonary embolism—Temozolomide—malignant glioma	0.000849	0.00545	CcSEcCtD
Cyclophosphamide—Influenza like illness—Temozolomide—malignant glioma	0.000825	0.00529	CcSEcCtD
Cyclophosphamide—Neoplasm—Carmustine—malignant glioma	0.000795	0.0051	CcSEcCtD
Cyclophosphamide—Neoplasm—Temozolomide—malignant glioma	0.000768	0.00492	CcSEcCtD
Cyclophosphamide—Sepsis—Carmustine—malignant glioma	0.000763	0.00489	CcSEcCtD
Cyclophosphamide—Phlebitis—Carmustine—malignant glioma	0.000741	0.00475	CcSEcCtD
Cyclophosphamide—Diabetes mellitus—Carmustine—malignant glioma	0.000733	0.0047	CcSEcCtD
Cyclophosphamide—Swelling—Carmustine—malignant glioma	0.000723	0.00464	CcSEcCtD
Cyclophosphamide—Gastroenteritis—Temozolomide—malignant glioma	0.000696	0.00446	CcSEcCtD
Cyclophosphamide—Deafness—Temozolomide—malignant glioma	0.000689	0.00442	CcSEcCtD
Cyclophosphamide—Hepatic failure—Temozolomide—malignant glioma	0.000686	0.0044	CcSEcCtD
Cyclophosphamide—Nasal congestion—Temozolomide—malignant glioma	0.000677	0.00434	CcSEcCtD
Cyclophosphamide—Hot flush—Temozolomide—malignant glioma	0.000659	0.00423	CcSEcCtD
Cyclophosphamide—Menopausal symptoms—Temozolomide—malignant glioma	0.000653	0.00419	CcSEcCtD
Cyclophosphamide—Hyponatraemia—Carmustine—malignant glioma	0.000641	0.00411	CcSEcCtD
Cyclophosphamide—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000638	0.00409	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000555	0.00356	CcSEcCtD
Cyclophosphamide—Pancytopenia—Carmustine—malignant glioma	0.000524	0.00336	CcSEcCtD
Cyclophosphamide—Sweating increased—Temozolomide—malignant glioma	0.000519	0.00333	CcSEcCtD
Cyclophosphamide—Pancytopenia—Temozolomide—malignant glioma	0.000506	0.00325	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Carmustine—malignant glioma	0.000497	0.00319	CcSEcCtD
Cyclophosphamide—Pneumonia—Carmustine—malignant glioma	0.000494	0.00317	CcSEcCtD
Cyclophosphamide—Weight increased—Temozolomide—malignant glioma	0.000485	0.00311	CcSEcCtD
Cyclophosphamide—Renal failure—Carmustine—malignant glioma	0.000483	0.0031	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Carmustine—malignant glioma	0.000482	0.00309	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Temozolomide—malignant glioma	0.000481	0.00308	CcSEcCtD
Cyclophosphamide—Stomatitis—Carmustine—malignant glioma	0.000479	0.00307	CcSEcCtD
Cyclophosphamide—Pneumonia—Temozolomide—malignant glioma	0.000478	0.00306	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000471	0.00302	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Temozolomide—malignant glioma	0.000466	0.00299	CcSEcCtD
Cyclophosphamide—Stomatitis—Temozolomide—malignant glioma	0.000463	0.00297	CcSEcCtD
Cyclophosphamide—Haemoglobin—Carmustine—malignant glioma	0.000444	0.00284	CcSEcCtD
Cyclophosphamide—Haemorrhage—Carmustine—malignant glioma	0.000441	0.00283	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Carmustine—malignant glioma	0.000439	0.00282	CcSEcCtD
Cyclophosphamide—Haemoglobin—Temozolomide—malignant glioma	0.000429	0.00275	CcSEcCtD
Cyclophosphamide—Haemorrhage—Temozolomide—malignant glioma	0.000426	0.00274	CcSEcCtD
Cyclophosphamide—Hepatitis—Temozolomide—malignant glioma	0.000426	0.00274	CcSEcCtD
Cyclophosphamide—Visual impairment—Carmustine—malignant glioma	0.000425	0.00273	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Temozolomide—malignant glioma	0.000424	0.00272	CcSEcCtD
Cyclophosphamide—Visual impairment—Temozolomide—malignant glioma	0.000411	0.00264	CcSEcCtD
Cyclophosphamide—Flushing—Carmustine—malignant glioma	0.00041	0.00263	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Temozolomide—malignant glioma	0.000403	0.00259	CcSEcCtD
Cyclophosphamide—Tinnitus—Temozolomide—malignant glioma	0.000398	0.00255	CcSEcCtD
Cyclophosphamide—Flushing—Temozolomide—malignant glioma	0.000396	0.00254	CcSEcCtD
Cyclophosphamide—Arrhythmia—Carmustine—malignant glioma	0.000394	0.00253	CcSEcCtD
Cyclophosphamide—Alopecia—Carmustine—malignant glioma	0.00039	0.0025	CcSEcCtD
Cyclophosphamide—Erythema—Carmustine—malignant glioma	0.000384	0.00246	CcSEcCtD
Cyclophosphamide—Chills—Temozolomide—malignant glioma	0.000383	0.00245	CcSEcCtD
Cyclophosphamide—Alopecia—Temozolomide—malignant glioma	0.000377	0.00242	CcSEcCtD
Cyclophosphamide—Erythema—Temozolomide—malignant glioma	0.000371	0.00238	CcSEcCtD
Cyclophosphamide—Dysgeusia—Temozolomide—malignant glioma	0.000364	0.00233	CcSEcCtD
Cyclophosphamide—Vision blurred—Carmustine—malignant glioma	0.000362	0.00232	CcSEcCtD
Cyclophosphamide—Tremor—Carmustine—malignant glioma	0.00036	0.00231	CcSEcCtD
Cyclophosphamide—Anaemia—Carmustine—malignant glioma	0.000355	0.00228	CcSEcCtD
Cyclophosphamide—Agitation—Carmustine—malignant glioma	0.000353	0.00226	CcSEcCtD
Cyclophosphamide—Vision blurred—Temozolomide—malignant glioma	0.00035	0.00224	CcSEcCtD
Cyclophosphamide—Tremor—Temozolomide—malignant glioma	0.000348	0.00223	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Temozolomide—malignant glioma	0.000344	0.00221	CcSEcCtD
Cyclophosphamide—Leukopenia—Carmustine—malignant glioma	0.000344	0.00221	CcSEcCtD
Cyclophosphamide—Anaemia—Temozolomide—malignant glioma	0.000343	0.0022	CcSEcCtD
Cyclophosphamide—Agitation—Temozolomide—malignant glioma	0.000341	0.00219	CcSEcCtD
Cyclophosphamide—Malaise—Temozolomide—malignant glioma	0.000335	0.00215	CcSEcCtD
Cyclophosphamide—Convulsion—Carmustine—malignant glioma	0.000333	0.00213	CcSEcCtD
Cyclophosphamide—Leukopenia—Temozolomide—malignant glioma	0.000332	0.00213	CcSEcCtD
Cyclophosphamide—Hypertension—Carmustine—malignant glioma	0.000332	0.00213	CcSEcCtD
Cyclophosphamide—Palpitations—Temozolomide—malignant glioma	0.000328	0.0021	CcSEcCtD
Cyclophosphamide—Chest pain—Carmustine—malignant glioma	0.000327	0.0021	CcSEcCtD
Cyclophosphamide—Myalgia—Carmustine—malignant glioma	0.000327	0.0021	CcSEcCtD
Cyclophosphamide—Cough—Temozolomide—malignant glioma	0.000324	0.00208	CcSEcCtD
Cyclophosphamide—Convulsion—Temozolomide—malignant glioma	0.000322	0.00206	CcSEcCtD
Cyclophosphamide—Hypertension—Temozolomide—malignant glioma	0.000321	0.00206	CcSEcCtD
Cyclophosphamide—Confusional state—Carmustine—malignant glioma	0.000316	0.00203	CcSEcCtD
Cyclophosphamide—Myalgia—Temozolomide—malignant glioma	0.000316	0.00203	CcSEcCtD
Cyclophosphamide—Arthralgia—Temozolomide—malignant glioma	0.000316	0.00203	CcSEcCtD
Cyclophosphamide—Oedema—Carmustine—malignant glioma	0.000314	0.00201	CcSEcCtD
Cyclophosphamide—Discomfort—Temozolomide—malignant glioma	0.000312	0.002	CcSEcCtD
Cyclophosphamide—Infection—Carmustine—malignant glioma	0.000312	0.002	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Carmustine—malignant glioma	0.000307	0.00197	CcSEcCtD
Cyclophosphamide—Tachycardia—Carmustine—malignant glioma	0.000306	0.00196	CcSEcCtD
Cyclophosphamide—Confusional state—Temozolomide—malignant glioma	0.000306	0.00196	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Temozolomide—malignant glioma	0.000303	0.00194	CcSEcCtD
Cyclophosphamide—Oedema—Temozolomide—malignant glioma	0.000303	0.00194	CcSEcCtD
Cyclophosphamide—Infection—Temozolomide—malignant glioma	0.000301	0.00193	CcSEcCtD
Cyclophosphamide—Anorexia—Carmustine—malignant glioma	0.000299	0.00192	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Temozolomide—malignant glioma	0.000297	0.0019	CcSEcCtD
Cyclophosphamide—Hypotension—Carmustine—malignant glioma	0.000293	0.00188	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Temozolomide—malignant glioma	0.000293	0.00188	CcSEcCtD
Cyclophosphamide—Anorexia—Temozolomide—malignant glioma	0.000289	0.00185	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000286	0.00183	CcSEcCtD
Cyclophosphamide—Paraesthesia—Carmustine—malignant glioma	0.000282	0.00181	CcSEcCtD
Cyclophosphamide—Dyspnoea—Carmustine—malignant glioma	0.00028	0.00179	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000276	0.00177	CcSEcCtD
Cyclophosphamide—Decreased appetite—Carmustine—malignant glioma	0.000273	0.00175	CcSEcCtD
Cyclophosphamide—Paraesthesia—Temozolomide—malignant glioma	0.000272	0.00175	CcSEcCtD
Cyclophosphamide—Dyspnoea—Temozolomide—malignant glioma	0.00027	0.00173	CcSEcCtD
Cyclophosphamide—Pain—Carmustine—malignant glioma	0.000268	0.00172	CcSEcCtD
Cyclophosphamide—Constipation—Carmustine—malignant glioma	0.000268	0.00172	CcSEcCtD
Cyclophosphamide—Decreased appetite—Temozolomide—malignant glioma	0.000263	0.00169	CcSEcCtD
Cyclophosphamide—Fatigue—Temozolomide—malignant glioma	0.000261	0.00168	CcSEcCtD
Cyclophosphamide—Pain—Temozolomide—malignant glioma	0.000259	0.00166	CcSEcCtD
Cyclophosphamide—Constipation—Temozolomide—malignant glioma	0.000259	0.00166	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Carmustine—malignant glioma	0.000258	0.00166	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Temozolomide—malignant glioma	0.00025	0.0016	CcSEcCtD
Cyclophosphamide—Body temperature increased—Carmustine—malignant glioma	0.000248	0.00159	CcSEcCtD
Cyclophosphamide—Urticaria—Temozolomide—malignant glioma	0.000241	0.00154	CcSEcCtD
Cyclophosphamide—Body temperature increased—Temozolomide—malignant glioma	0.00024	0.00154	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Carmustine—malignant glioma	0.000231	0.00148	CcSEcCtD
Cyclophosphamide—Asthenia—Carmustine—malignant glioma	0.000225	0.00144	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Temozolomide—malignant glioma	0.000223	0.00143	CcSEcCtD
Cyclophosphamide—Asthenia—Temozolomide—malignant glioma	0.000217	0.00139	CcSEcCtD
Cyclophosphamide—Diarrhoea—Carmustine—malignant glioma	0.000215	0.00138	CcSEcCtD
Cyclophosphamide—Pruritus—Temozolomide—malignant glioma	0.000214	0.00137	CcSEcCtD
Cyclophosphamide—Dizziness—Carmustine—malignant glioma	0.000207	0.00133	CcSEcCtD
Cyclophosphamide—Diarrhoea—Temozolomide—malignant glioma	0.000207	0.00133	CcSEcCtD
Cyclophosphamide—Dizziness—Temozolomide—malignant glioma	0.0002	0.00129	CcSEcCtD
Cyclophosphamide—Vomiting—Carmustine—malignant glioma	0.000199	0.00128	CcSEcCtD
Cyclophosphamide—Rash—Carmustine—malignant glioma	0.000198	0.00127	CcSEcCtD
Cyclophosphamide—Dermatitis—Carmustine—malignant glioma	0.000198	0.00127	CcSEcCtD
Cyclophosphamide—Headache—Carmustine—malignant glioma	0.000196	0.00126	CcSEcCtD
Cyclophosphamide—Vomiting—Temozolomide—malignant glioma	0.000193	0.00124	CcSEcCtD
Cyclophosphamide—Rash—Temozolomide—malignant glioma	0.000191	0.00123	CcSEcCtD
Cyclophosphamide—Dermatitis—Temozolomide—malignant glioma	0.000191	0.00122	CcSEcCtD
Cyclophosphamide—Headache—Temozolomide—malignant glioma	0.00019	0.00122	CcSEcCtD
Cyclophosphamide—Nausea—Carmustine—malignant glioma	0.000186	0.00119	CcSEcCtD
Cyclophosphamide—Nausea—Temozolomide—malignant glioma	0.00018	0.00115	CcSEcCtD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.9e-05	0.000231	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	1.87e-05	0.000227	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—BCAN—malignant glioma	1.85e-05	0.000225	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—IDH1—malignant glioma	1.84e-05	0.000224	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—BCAN—malignant glioma	1.83e-05	0.000223	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—NCOR1—malignant glioma	1.83e-05	0.000222	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	1.82e-05	0.000222	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—IDH2—malignant glioma	1.81e-05	0.000221	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—IDH1—malignant glioma	1.8e-05	0.000219	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS1—malignant glioma	1.79e-05	0.000218	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—SPHK1—malignant glioma	1.78e-05	0.000217	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	1.75e-05	0.000213	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GSTT1—malignant glioma	1.75e-05	0.000213	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP2C18—malignant glioma	1.75e-05	0.000212	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—SPHK1—malignant glioma	1.74e-05	0.000212	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.71e-05	0.000208	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP2C18—malignant glioma	1.71e-05	0.000208	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP2B6—malignant glioma	1.7e-05	0.000207	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—BCHE—malignant glioma	1.66e-05	0.000202	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—SLC5A5—malignant glioma	1.64e-05	0.0002	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS1—malignant glioma	1.64e-05	0.000199	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—IDH2—malignant glioma	1.62e-05	0.000197	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.58e-05	0.000193	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—IDH2—malignant glioma	1.58e-05	0.000192	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—IDH1—malignant glioma	1.56e-05	0.00019	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.53e-05	0.000186	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—BCHE—malignant glioma	1.52e-05	0.000185	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.52e-05	0.000185	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—COX8A—malignant glioma	1.51e-05	0.000184	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—SPHK1—malignant glioma	1.51e-05	0.000184	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—SLC5A5—malignant glioma	1.51e-05	0.000183	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CAV1—malignant glioma	1.49e-05	0.000181	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—IDH2—malignant glioma	1.49e-05	0.000181	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP2B6—malignant glioma	1.49e-05	0.000181	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP2C18—malignant glioma	1.48e-05	0.00018	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—IDH2—malignant glioma	1.48e-05	0.000179	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.46e-05	0.000177	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.43e-05	0.000173	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTT1—malignant glioma	1.41e-05	0.000172	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.4e-05	0.00017	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.39e-05	0.00017	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—IDH1—malignant glioma	1.39e-05	0.000169	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.39e-05	0.000169	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.39e-05	0.000169	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTT1—malignant glioma	1.38e-05	0.000168	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CG—malignant glioma	1.36e-05	0.000165	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—IDH1—malignant glioma	1.36e-05	0.000165	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.36e-05	0.000165	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.35e-05	0.000164	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—SPHK1—malignant glioma	1.35e-05	0.000164	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GSTP1—malignant glioma	1.32e-05	0.000161	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS1—malignant glioma	1.32e-05	0.000161	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.32e-05	0.00016	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—SPHK1—malignant glioma	1.31e-05	0.00016	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PPARG—malignant glioma	1.31e-05	0.000159	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS1—malignant glioma	1.29e-05	0.000157	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CAT—malignant glioma	1.29e-05	0.000157	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP2C18—malignant glioma	1.29e-05	0.000157	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ASMT—malignant glioma	1.28e-05	0.000156	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—IDH1—malignant glioma	1.28e-05	0.000156	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.27e-05	0.000154	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—IDH1—malignant glioma	1.27e-05	0.000154	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.24e-05	0.000151	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—SPHK1—malignant glioma	1.24e-05	0.000151	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.24e-05	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—BCHE—malignant glioma	1.23e-05	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—SPHK1—malignant glioma	1.23e-05	0.000149	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.23e-05	0.000149	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—NCOR1—malignant glioma	1.22e-05	0.000148	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.22e-05	0.000148	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.21e-05	0.000148	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GSTP1—malignant glioma	1.21e-05	0.000148	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—BCAN—malignant glioma	1.21e-05	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.2e-05	0.000146	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—BCHE—malignant glioma	1.2e-05	0.000146	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.2e-05	0.000146	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTT1—malignant glioma	1.2e-05	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CD—malignant glioma	1.19e-05	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.19e-05	0.000144	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CAT—malignant glioma	1.18e-05	0.000144	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.13e-05	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.13e-05	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS1—malignant glioma	1.12e-05	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.12e-05	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—NCOR1—malignant glioma	1.11e-05	0.000136	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.09e-05	0.000133	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTT1—malignant glioma	1.07e-05	0.00013	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTT1—malignant glioma	1.04e-05	0.000127	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—BCHE—malignant glioma	1.04e-05	0.000127	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CB—malignant glioma	1.04e-05	0.000127	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.03e-05	0.000126	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTGS2—malignant glioma	1.03e-05	0.000125	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.03e-05	0.000125	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.01e-05	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS1—malignant glioma	1e-05	0.000122	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.97e-06	0.000121	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.96e-06	0.000121	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CAV1—malignant glioma	9.91e-06	0.000121	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTT1—malignant glioma	9.81e-06	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTP1—malignant glioma	9.79e-06	0.000119	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS1—malignant glioma	9.76e-06	0.000119	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—IDH2—malignant glioma	9.73e-06	0.000118	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTT1—malignant glioma	9.73e-06	0.000118	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.73e-06	0.000118	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.64e-06	0.000117	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTP1—malignant glioma	9.57e-06	0.000116	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CAT—malignant glioma	9.52e-06	0.000116	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CAT—malignant glioma	9.31e-06	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—BCHE—malignant glioma	9.3e-06	0.000113	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS1—malignant glioma	9.2e-06	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—SLC5A5—malignant glioma	9.18e-06	0.000112	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP2B6—malignant glioma	9.15e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS1—malignant glioma	9.12e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CAV1—malignant glioma	9.09e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.08e-06	0.00011	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—BCHE—malignant glioma	9.07e-06	0.00011	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CG—malignant glioma	9.03e-06	0.00011	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—NCOR1—malignant glioma	8.99e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTEN—malignant glioma	8.99e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—SLC5A5—malignant glioma	8.96e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—NCOR1—malignant glioma	8.79e-06	0.000107	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PPARG—malignant glioma	8.72e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.68e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.6e-06	0.000105	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—BCHE—malignant glioma	8.55e-06	0.000104	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—BCHE—malignant glioma	8.48e-06	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—SLC5A5—malignant glioma	8.45e-06	0.000103	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.41e-06	0.000102	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—SLC5A5—malignant glioma	8.37e-06	0.000102	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—IDH1—malignant glioma	8.37e-06	0.000102	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTP1—malignant glioma	8.29e-06	0.000101	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CG—malignant glioma	8.28e-06	0.000101	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	8.25e-06	0.0001	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SPHK1—malignant glioma	8.1e-06	9.85e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CAT—malignant glioma	8.06e-06	9.81e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PPARG—malignant glioma	7.99e-06	9.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CD—malignant glioma	7.94e-06	9.66e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP2C18—malignant glioma	7.93e-06	9.65e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.92e-06	9.63e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.85e-06	9.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—NCOR1—malignant glioma	7.61e-06	9.26e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.5e-06	9.13e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTP1—malignant glioma	7.4e-06	9e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CAV1—malignant glioma	7.33e-06	8.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CD—malignant glioma	7.28e-06	8.85e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTP1—malignant glioma	7.22e-06	8.78e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CAT—malignant glioma	7.2e-06	8.75e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CAV1—malignant glioma	7.17e-06	8.72e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CAT—malignant glioma	7.02e-06	8.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CB—malignant glioma	6.92e-06	8.42e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS2—malignant glioma	6.86e-06	8.34e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.84e-06	8.32e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTP1—malignant glioma	6.8e-06	8.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—NCOR1—malignant glioma	6.8e-06	8.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTP1—malignant glioma	6.74e-06	8.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CG—malignant glioma	6.68e-06	8.12e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—NCOR1—malignant glioma	6.63e-06	8.07e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CAT—malignant glioma	6.62e-06	8.05e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CAT—malignant glioma	6.56e-06	7.98e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CG—malignant glioma	6.53e-06	7.94e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PPARG—malignant glioma	6.45e-06	7.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTT1—malignant glioma	6.42e-06	7.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PIK3CA—malignant glioma	6.35e-06	7.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CB—malignant glioma	6.34e-06	7.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PPARG—malignant glioma	6.3e-06	7.66e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS2—malignant glioma	6.28e-06	7.64e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—NCOR1—malignant glioma	6.25e-06	7.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CAV1—malignant glioma	6.21e-06	7.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—NCOR1—malignant glioma	6.2e-06	7.54e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS1—malignant glioma	6.01e-06	7.31e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTEN—malignant glioma	5.98e-06	7.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.93e-06	7.21e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CD—malignant glioma	5.87e-06	7.14e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CD—malignant glioma	5.74e-06	6.98e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CG—malignant glioma	5.65e-06	6.88e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—BCHE—malignant glioma	5.59e-06	6.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CAV1—malignant glioma	5.54e-06	6.74e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.52e-06	6.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTEN—malignant glioma	5.48e-06	6.67e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PPARG—malignant glioma	5.46e-06	6.64e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CAV1—malignant glioma	5.41e-06	6.58e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.29e-06	6.44e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—AKT1—malignant glioma	5.18e-06	6.3e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CB—malignant glioma	5.12e-06	6.22e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CAV1—malignant glioma	5.1e-06	6.2e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS2—malignant glioma	5.07e-06	6.17e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CAV1—malignant glioma	5.05e-06	6.14e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.05e-06	6.14e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CB—malignant glioma	5e-06	6.08e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CD—malignant glioma	4.97e-06	6.05e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS2—malignant glioma	4.96e-06	6.03e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CG—malignant glioma	4.93e-06	5.99e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PPARG—malignant glioma	4.87e-06	5.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.83e-06	5.87e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PPARG—malignant glioma	4.75e-06	5.78e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.64e-06	5.65e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.6e-06	5.6e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PPARG—malignant glioma	4.48e-06	5.45e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTP1—malignant glioma	4.45e-06	5.41e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PPARG—malignant glioma	4.44e-06	5.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.44e-06	5.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTEN—malignant glioma	4.42e-06	5.38e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CB—malignant glioma	4.33e-06	5.27e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CD—malignant glioma	4.33e-06	5.27e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CAT—malignant glioma	4.33e-06	5.26e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTEN—malignant glioma	4.32e-06	5.26e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS2—malignant glioma	4.29e-06	5.22e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PIK3CA—malignant glioma	4.22e-06	5.13e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NCOR1—malignant glioma	4.09e-06	4.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.08e-06	4.96e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.05e-06	4.92e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CB—malignant glioma	3.87e-06	4.7e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PIK3CA—malignant glioma	3.87e-06	4.7e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS2—malignant glioma	3.83e-06	4.66e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CB—malignant glioma	3.77e-06	4.59e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTEN—malignant glioma	3.74e-06	4.55e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS2—malignant glioma	3.74e-06	4.55e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.56e-06	4.33e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.53e-06	4.29e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS2—malignant glioma	3.52e-06	4.29e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS2—malignant glioma	3.49e-06	4.25e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—AKT1—malignant glioma	3.45e-06	4.19e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTEN—malignant glioma	3.34e-06	4.06e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CAV1—malignant glioma	3.33e-06	4.05e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTEN—malignant glioma	3.26e-06	3.97e-05	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—AKT1—malignant glioma	3.16e-06	3.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.12e-06	3.79e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTEN—malignant glioma	3.07e-06	3.74e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.05e-06	3.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTEN—malignant glioma	3.05e-06	3.71e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.03e-06	3.69e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PPARG—malignant glioma	2.93e-06	3.56e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.67e-06	3.24e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.64e-06	3.21e-05	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—AKT1—malignant glioma	2.55e-06	3.1e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—AKT1—malignant glioma	2.49e-06	3.03e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.36e-06	2.87e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.33e-06	2.83e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS2—malignant glioma	2.3e-06	2.8e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PIK3CA—malignant glioma	2.3e-06	2.8e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.17e-06	2.64e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—AKT1—malignant glioma	2.16e-06	2.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.15e-06	2.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTEN—malignant glioma	2.01e-06	2.44e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—AKT1—malignant glioma	1.93e-06	2.34e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—AKT1—malignant glioma	1.88e-06	2.29e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—AKT1—malignant glioma	1.77e-06	2.15e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—AKT1—malignant glioma	1.76e-06	2.14e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.42e-06	1.72e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—AKT1—malignant glioma	1.16e-06	1.41e-05	CbGpPWpGaD
